10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.
Clinical trial NCT01260922 · COMPLETED
Trial details
- NCT number
- NCT01260922
- Sponsor
- Teva Pharmaceuticals USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2006-05-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.